openPR Logo
Press release

Rytary/IPX066 (Parkinsons Disease) - Forecast And Market Analysis To 2022

11-15-2016 09:36 AM CET | Health & Medicine

Press release from: Parkinsons Disease

Summary

Parkinsons disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinsons disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. Dopaminergic therapies have been fairly effective in treating bradykinesia, but several unmet needs remain. Some needs will be met during the forecast period from 2012-2022, while others, such as the need for disease-modifying drugs, will remain. GlobalData expects that advancements will be made in levodopa administration and that four new molecular entities will be introduced to the market by 2022, these factors along with increased patient numbers from an aging population will drive the market during the forecast period.

Rytary, also known as IPX066, is a levodopa-based product for the treatment of early and advanced Parkinsons disease. It was developed by the generics manufacturer Impax Laboratories and contains a capsule with different-sized beads that dissolve at different rates, releasing a 1:4 ratio of carbidopa: levodopa.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/197524

Scope

- Overview of Parkinsons disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Rytary including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Rytary for the top six countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain and the UK.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Parkinsons disease
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Rytary performance
- Obtain sales forecast for Rytary from 2012-2022 in the top six countries (the US, France, Germany, Italy, Spain and the UK).

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rytary/IPX066 (Parkinsons Disease) - Forecast And Market Analysis To 2022 here

News-ID: 382497 • Views: 293

More Releases from Parkinsons Disease

Parkinsons Disease - Heat Map and Analysis | Industry Key Trends, Size, Growth, …
Researchmoz added latest report "Parkinsons Disease - Heat Map and Analysis". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear
Symptomatic Treatments On Parkinsons Disease - Heat Map and Analysis
Researchmoz added Most up-to-date research on "Symptomatic Treatments On Parkinsons Disease - Heat Map and Analysis" to its huge collection of research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties, and progress in varying
Parkinsons Disease - Heat Map and Analysis Industry Key Trends, Size, Growth, Sh …
Researchmoz added Most up-to-date research on "Parkinsons Disease - Heat Map and Analysis" to its huge collection of research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties, and progress in varying stages. There is currently
Parkinsons Disease Industry : Insights, Development, Research and Forecast 2017
Albany, NY, 21st FEB : Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties, and progress in varying stages. Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=970727 There is currently no cure for PD,

All 5 Releases


More Releases for Rytary

How Parkinson Disease Drugs Market Will Dominate In Coming Years? Key Players: P …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby
How Parkinson Disease Drugs Market Will Dominate In Coming Years? Key Players: P …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby
Growth Dynamics on Parkinson's Disease Drugs Market 2020-2026| Key Players: Pfiz …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby
Growth Dynamics on Parkinson's Disease Drugs Market 2020-2026| Key Players: Pfiz …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby
Growth Dynamics on Parkinson's Disease Drugs Market 2020-2026| Key Players: Pfiz …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby
Growth Dynamics on Parkinson's Disease Drugs Market 2020-2026| Key Players: Pfiz …
The Global Parkinson's Disease Drugs Market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby